Literature DB >> 29658577

Interleukin 29 activates expression of tissue inhibitor of metalloproteinase 1 in macrophages via toll‑like receptor 2.

Haoqiang Zhang1, Bing Song1, Shaoheng He2.   

Abstract

Obesity and diabetes are characterized by low grade chronic inflammation status and insulin resistance in adipose tissue associated with metalloproteinase inhibitor 1 (TIMP1). Interleukin (IL)29, exhibits multiple immune regulatory activities. However, the role of IL29 and its effects on TIMP1 remain to be elucidated. The present study was designed to investigate the effects of IL29 on expression of TIMP1 in macrophages associated with inflammation in adipose tissue. IL29 and high glucose were used to activate Raw264.7 cells and primary macrophages with or without antibody‑mediated inhibition of toll like receptor (TLR) 2 and TLR4. TIMP1 was measured in culture media of Raw264.7 cells and primary macrophages by ELISA. IL29 and high glucose increased TIMP1 levels in Raw264.7 cells and primary macrophages. Antibody‑mediated inhibition of TLR2 or TLR2 gene knockout decreased TIMP1 levels activated by IL29, however not by high glucose in the medium of Raw264.7 cells and primary macrophages. Furthermore, antibody‑mediated inhibition of TLR4 or TLR4 gene knockout decreased TIMP1 levels which were stimulated by high glucose, not by IL29 in the medium of Raw264.7 cells and primary macrophages. The results of the present study indicate that TLR2 is involved in IL29‑stimulated TIMP1 expression in Raw264.7 cells and primary macrophages.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29658577     DOI: 10.3892/mmr.2018.8865

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

Review 1.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

2.  Mechanism of protection from insulin resistance by toll-like receptor 2 deficiency in high-fat diet fed mice: involvement in macrophage polarization.

Authors:  Yu Ma; Xinyue Liu; Yaliu Wu; Wendong Wang; Xiaotong Chang
Journal:  Mol Biol Rep       Date:  2022-01-16       Impact factor: 2.316

3.  Sp1 induced gene TIMP1 is related to immune cell infiltration in glioblastoma.

Authors:  Lu Liu; Shuyao Yang; Kefeng Lin; Xiaoman Yu; Jiaqi Meng; Chao Ma; Zheng Wu; Yuchao Hao; Ning Chen; Qi Ge; Wenli Gao; Xiang Wang; Eric W-F Lam; Lin Zhang; Fangcheng Li; Bilian Jin; Di Jin
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

4.  1α,25-Dihydroxyvitamin D3 Encapsulated in Nanoparticles Prevents Venous Neointimal Hyperplasia and Stenosis in Porcine Arteriovenous Fistulas.

Authors:  Avishek K Singh; Chuanqi Cai; Sreenivasulu Kilari; Chenglei Zhao; Michael L Simeon; Edwin Takahashi; Elazer R Edelman; Hyunjoon Joon Kong; Thanila Macedo; Ravinder J Singh; Matthew W Urban; Rajiv Kumar; Sanjay Misra
Journal:  J Am Soc Nephrol       Date:  2021-02-24       Impact factor: 10.121

5.  Liraglutide improved the cognitive function of diabetic mice via the receptor of advanced glycation end products down-regulation.

Authors:  Haoqiang Zhang; Yafen Chu; Hongwei Zheng; Jing Wang; Bing Song; Yao Sun
Journal:  Aging (Albany NY)       Date:  2020-11-26       Impact factor: 5.682

6.  Emodin Attenuated the Kidney Damage of High-Fat-Diet Mice via the Upregulation of Glucagon-Like Peptide-1 Receptor.

Authors:  Jinlei Liu; Yao Sun; Hongwei Zheng; Jing Wang; Lili Liu; Bing Song; Haoqiang Zhang
Journal:  Biomed Res Int       Date:  2021-05-31       Impact factor: 3.411

7.  Ginsenoside Rb1 Alleviated High-Fat-Diet-Induced Hepatocytic Apoptosis via Peroxisome Proliferator-Activated Receptor γ.

Authors:  Bing Song; Yao Sun; Yafen Chu; Jing Wang; Hongwei Zheng; Lili Liu; Wang Cai; Haoqiang Zhang
Journal:  Biomed Res Int       Date:  2020-07-13       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.